Home / Publication / Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

論文

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Perhaps the most important lesson learned from the COVID‐19 pandemic is that of preparedness. Enhanced surveillance systems for early threat detection will be crucial to maximizing response time for implementation of public health measures (…)

Author(s): Jasmine Davda, Kellie Reynold, John D. Davis, Patrick F. Smith

Year: 2021年4月14日

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

ビデオ

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

科学を越えて：Meet Sr. Director Craig Comisar

Meet Floris Fauchet: From Model-Based Drug Development to Martial Arts

メルマガ登録

クイックアクセス

ソリューション

お問合せ